Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Zander

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|March 6, 2009
Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donorsSunday Ocheni, Tatjana Zabelina, Ulrike Bacher, et al.
Experimental Hematology|May 27, 2006
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission statusNicolaus Kröger, Tatjana Zabelina, Francis Ayuk, et al.
Leukemia & Lymphoma|October 29, 2009
Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantationIrene Cavattoni, Tatjana Zabelina, Francis Ayuk, et al.
Experimental and Clinical Cardiology|July 31, 2009
Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarctionKorff Krause, Boris Fehse, Kai Jaquet, et al.
Experimental Hematology|May 2, 2006
Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myelomaNicolaus Kröger, Maria Zagrivnaja, Sabine Schwartz, et al.
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
British Journal of Haematology|January 21, 2010
Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord bloodVarda Deutsch, Einav Hubel, Sigi Kay, et al.
Bone Marrow Transplantation|July 13, 2022
Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantationRadwan Massoud, Evgeny Klyuchnikov, Nico Gagelmann, et al.
Transplantation|October 25, 2006
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantationNicolaus Kröger, Thomas Binder, Tatjana Zabelina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2018
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell TransplantationMaximilian Gröger, Nico Gagelmann, Christine Wolschke, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|March 6, 2009
Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donorsSunday Ocheni, Tatjana Zabelina, Ulrike Bacher, et al.
Experimental Hematology|May 27, 2006
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission statusNicolaus Kröger, Tatjana Zabelina, Francis Ayuk, et al.
Leukemia & Lymphoma|October 29, 2009
Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantationIrene Cavattoni, Tatjana Zabelina, Francis Ayuk, et al.
Experimental and Clinical Cardiology|July 31, 2009
Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarctionKorff Krause, Boris Fehse, Kai Jaquet, et al.
Experimental Hematology|May 2, 2006
Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myelomaNicolaus Kröger, Maria Zagrivnaja, Sabine Schwartz, et al.
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
British Journal of Haematology|January 21, 2010
Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord bloodVarda Deutsch, Einav Hubel, Sigi Kay, et al.
Bone Marrow Transplantation|July 13, 2022
Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantationRadwan Massoud, Evgeny Klyuchnikov, Nico Gagelmann, et al.
Transplantation|October 25, 2006
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantationNicolaus Kröger, Thomas Binder, Tatjana Zabelina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2018
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell TransplantationMaximilian Gröger, Nico Gagelmann, Christine Wolschke, et al.
Pageof 4